# Erratum: Delimiting MOGAD as a disease entity using translational imaging

PMC · DOI: 10.3389/fneur.2024.1390688 · Frontiers in Neurology · 2024-03-07

## Full-text entities

- **Genes:** NDI1 (NADH-ubiquinone reductase (H(+)-translocating) NDI1) [NCBI Gene 854919], MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}
- **Diseases:** EAE (MESH:D004681), acute disseminated encephalomyelitis (MESH:D004673), acquired demyelinating syndrome (MESH:D003711), MS (MESH:D009103), optic atrophy (MESH:D009896), visual loss (MESH:D014786)
- **Chemicals:** Natalizumab (MESH:D000069442), Fingolimod (MESH:D000068876)
- **Species:** Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10956577/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC10956577/full.md

---
Source: https://tomesphere.com/paper/PMC10956577